Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated

How Xanthinuria is Diagnosed

At a Glance

Hereditary xanthinuria is typically diagnosed when routine blood tests reveal near-zero uric acid levels. Doctors confirm the diagnosis using a 24-hour urine test showing high xanthine, specialized analysis of kidney stones, and genetic testing of the XDH or MOCOS genes to determine the exact type.

Diagnosing hereditary xanthinuria usually begins with a surprise discovery on a routine blood test. Because the condition is rare and often has no symptoms, it is frequently found when a doctor notices that your uric acid levels are almost non-existent [1][2].

Confirming the diagnosis requires a step-by-step approach to rule out other conditions and pinpoint exactly which ‘biological worker’ (enzyme) is affected.

The Biochemical ‘Smoking Gun’

The first sign of xanthinuria is hypouricemia, defined as a serum uric acid level of 2.0 mg/dL or lower [3][4]. However, low uric acid can happen for many reasons, so doctors look for a specific pattern in both your blood and urine [5]:

  • Serum (Blood) Uric Acid: Extremely low, often near zero [2].
  • Urinary Uric Acid: Also profoundly low, because the body isn’t making it [6].
  • Urinary Xanthine: Markedly elevated. While a person without the condition might have less than 30 mmol of xanthine per mol of creatinine, a patient with xanthinuria may have levels between 170 and 598 mmol [2].

Analyzing ‘Invisible’ Stones

If you have kidney stones, they provide a vital piece of the diagnostic puzzle. However, xanthine stones are radiolucent, meaning they do not show up on standard X-rays [7].

If a stone is retrieved through surgery or passed naturally, it must be sent for specialized analysis. Standard chemical tests used by some labs are often insufficient for identifying rare stones like these [8]. Medical guidelines recommend two specific physical methods for definitive identification [8][9]:

  1. Infrared Spectroscopy (IRS): Uses light to identify the unique ‘fingerprint’ of xanthine crystals.
  2. X-ray Diffraction (XRD): Analyzes how X-rays bounce off the stone’s crystal structure to identify its makeup.

Genetic Testing: The Final Confirmation

While lab values can suggest xanthinuria, molecular genetic testing is the gold standard for confirming the diagnosis and determining the specific type [10][11].

A simple blood or saliva test can check two specific genes:

  • XDH Gene: If mutations are found here, you have Type I [12].
  • MOCOS Gene: Mutations here indicate Type II [13].

Knowing your genetic type is more than just a label—it helps your doctor know if you have a combined deficiency that might affect how you process certain medications [13]. Occasionally, an allopurinol loading test might be used to observe how your body processes purines, further aiding the clinical diagnosis [5].

Diagnostic Completeness Checklist

When reviewing your records with your doctor, ensure you have the following results to complete the diagnostic picture:

  • Serum Uric Acid: Is it 2.0 mg/dL or below? [3]
  • 24-Hour Urine Collection: Does it show high xanthine and low uric acid? [2]
  • Renal Function Tests: Have your creatinine and eGFR been checked to ensure your kidneys are healthy? [2]
  • Stone Analysis (if applicable): Was the stone analyzed using Infrared Spectroscopy or X-ray Diffraction? [8]
  • Genetic Testing: Have the XDH and MOCOS genes been analyzed? [11]

Common questions in this guide

How is hereditary xanthinuria first discovered?
The condition is often discovered accidentally during routine blood tests when a doctor notices that your serum uric acid levels are extremely low or near zero.
What tests are used to confirm a xanthinuria diagnosis?
Doctors look for profoundly low uric acid in both your blood and urine, combined with very high levels of xanthine in a 24-hour urine collection. Genetic testing is then used as the gold standard to finalize the diagnosis.
Why didn't my kidney stones show up on an X-ray?
Xanthine stones are radiolucent, which means they are invisible on standard X-rays. If a stone is retrieved, it must be analyzed using specialized physical methods like infrared spectroscopy or X-ray diffraction.
What is the difference between Type I and Type II xanthinuria?
The types are determined by which specific gene has a mutation. Type I is caused by mutations in the XDH gene, while Type II is caused by mutations in the MOCOS gene. A blood or saliva genetic test can identify your type.
Does a low uric acid level always mean I have xanthinuria?
No, low uric acid (hypouricemia) can happen for various reasons. To diagnose xanthinuria specifically, doctors must also find elevated xanthine levels in your urine or identify xanthine crystals in a kidney stone.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my exact serum uric acid level? Is it below the 2.0 mg/dL threshold for hypouricemia?
  2. 2.Did my 24-hour urine test show elevated xanthine levels? How many times higher than normal was it?
  3. 3.Can we order genetic testing for the XDH and MOCOS genes to confirm if I have Type I or Type II?
  4. 4.If I have a stone, will you ensure it is analyzed using infrared spectroscopy or X-ray diffraction, since standard chemical tests might miss xanthine?
  5. 5.Do I need an allopurinol loading test to help clarify my diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Identification of a new mutation in the human xanthine dehydrogenase responsible for xanthinuria type I.

    Collazo Abal C, Romero Santos S, González Mao C, et al.

    Advances in laboratory medicine 2021; (2(4)):567-574 doi:10.1515/almed-2021-0018.

    PMID: 37360896
  2. 2

    Hereditary xanthinuria is not so rare disorder of purine metabolism.

    Sebesta I, Stiburkova B, Krijt J

    Nucleosides, nucleotides & nucleic acids 2018; (37(6)):324-328 doi:10.1080/15257770.2018.1460478.

    PMID: 29723117
  3. 3

    Drug-Induced Hypouricemia.

    Ben Salem C, Agrebi M, Sahnoun D, et al.

    Drug safety 2025; (48(2)):129-142 doi:10.1007/s40264-024-01485-7.

    PMID: 39289314
  4. 4

    Hypouricemia and Urate Transporters.

    Otani N, Ouchi M, Misawa K, et al.

    Biomedicines 2022; (10(3)) doi:10.3390/biomedicines10030652.

    PMID: 35327453
  5. 5

    Xanthinuria type I with a novel mutation of xanthine dehydrogenase.

    Tanaka K, Kanazawa I, Yamasaki H, et al.

    The American journal of the medical sciences 2015; (350(2)):155-6 doi:10.1097/MAJ.0000000000000498.

    PMID: 26110747
  6. 6

    Association of Mutations Identified in Xanthinuria with the Function and Inhibition Mechanism of Xanthine Oxidoreductase.

    Sekine M, Okamoto K, Ichida K

    Biomedicines 2021; (9(11)) doi:10.3390/biomedicines9111723.

    PMID: 34829959
  7. 7

    The Predictive Accuracy of Hounsfield Units and Urinary pH in the Non-invasive Diagnosis of Radiolucent Urinary Stones.

    Hussain M, Alawadi A, Smith Y, et al.

    Cureus 2025; (17(9)):e91878 doi:10.7759/cureus.91878.

    PMID: 41080314
  8. 8

    Quality Assessment of Urinary Stone Analysis: Results of a Multicenter Study of Laboratories in Europe.

    Siener R, Buchholz N, Daudon M, et al.

    PloS one 2016; (11(6)):e0156606 doi:10.1371/journal.pone.0156606.

    PMID: 27248840
  9. 9

    Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

    Daudon M, Frochot V, Bazin D, Jungers P

    Drugs 2018; (78(2)):163-201 doi:10.1007/s40265-017-0853-7.

    PMID: 29264783
  10. 10

    Classical Xanthinuria in Nine Israeli Families and Two Isolated Cases from Germany: Molecular, Biochemical and Population Genetics Aspects.

    Peretz H, Lagziel A, Bittner F, et al.

    Biomedicines 2021; (9(7)) doi:10.3390/biomedicines9070788.

    PMID: 34356852
  11. 11

    Urolithiasis due to Hereditary Xanthinuria Type II: A Long-term Follow-up report.

    Kubihal S, Goyal A, Singla R, Khadgawat R

    Indian pediatrics 2020; (57(5)):468-469.

    PMID: 32444521
  12. 12

    A case of xanthinuria type I with a novel mutation in xanthine dehydrogenase.

    Iguchi A, Sato T, Yamazaki M, et al.

    CEN case reports 2016; (5(2)):158-162 doi:10.1007/s13730-016-0216-3.

    PMID: 28508967
  13. 13

    Clinical and genetic analysis of MOCOS gene-related hypouricemia.

    Peng H, Tu P, Ma Q, et al.

    Frontiers in genetics 2025; (16()):1636032 doi:10.3389/fgene.2025.1636032.

    PMID: 41164817

This page explains the diagnostic process for hereditary xanthinuria for educational purposes only. Always consult your nephrologist or geneticist to interpret your specific lab tests and stone analysis results.

Get notified when new evidence is published on Hereditary xanthinuria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.